Intermolecular Structure Conversion-Based G4-TDF Nanostructures Functionalized μPADs for Fluorescent Determination of Potassium Ion in Serum.
Human subjects
Names both Potassium and Tenofovir Disoproxil in its title.
Supplement × Prescription·Evidence index
PubMed indexes 4 records that name Potassium and Tenofovir Disoproxil together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.
Every statement below is attributed to a named, dated, linked source.
This page lists published research relevant to Potassium and Tenofovir Disoproxil. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.
Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.
Names both Potassium and Tenofovir Disoproxil in its title.
“TDF-containing ART regimen is associated with decreased eGFR, creatinine clearance and proteinuria.”
Names Potassium and Tenofovir Disoproxil together in an interaction, co-administration, or pharmacokinetic context.
“We found that 24-week treatment of HIV-infected patients with lithium and TDF did not result in increased nephrotoxicity. Trial registration The study was registered on the Pan African Clinical Trials Registry (PACTR) with the identifier number PACTR201310000635418. Registered 11 October 2013 before the first participant was enrolled.”
Names Potassium and Tenofovir Disoproxil together in an interaction, co-administration, or pharmacokinetic context.
Names Potassium and Tenofovir Disoproxil together in an interaction, co-administration, or pharmacokinetic context.
Search-based evidence indexes have real limits, and it is worth being explicit about them:
NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Potassium, Tenofovir Disoproxil, and several hundred other substances.
The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.